Oxford vaccine against deadly Nipah virus granted European Medicines Agency PRIME designation

Published on June 9, 2025

The University of Oxford’s vaccine to protect people from deadly Nipah virus has been granted support from the PRIority MEdicines (PRIME) scheme offered by Europe’s medicines regulator, the European Medicines Agency (EMA). It is the first UK academic institution to be awarded this designation.
Continue reading on website
Other news

Whistleblowing tech based on Cambridge research launched by the Guardian

June 9, 2025
The Guardian has launched Secure Messaging as a module within its mobile news app to provide a secure and usable method of establishing initial contact between journalists and sources.It builds on a technology - CoverDrop –developed by Cambridge researchers and includes a wide range of security features. The code is available online and is open source, to encourage adoption by other news organisat

Cambridge and Manchester partnership to boost UK innovation and growth gets government backing

June 9, 2025
The Cambridge x Manchester Innovation Partnership – the first trans-UK innovation collaboration of its kind – will receive £4.8m of funding from Research England over three years, it has been announced. With further investment from the two universities, the total funding for the partnership will be £6m. The initiative aims to strengthen research networks, accelerate scale-up growth, drive private